宁波美诺华药业股份有限公司关于召开2026年第一次临时股东会的通知

Group 1 - The company will hold its first extraordinary general meeting of 2026 on February 2, 2026, at 14:00 [2][4] - Shareholders can vote through the Shanghai Stock Exchange's online voting system during specified time slots on the meeting day [2][4] - The meeting will include both on-site and online voting methods, with the location being in Ningbo, Zhejiang Province [4][10] Group 2 - The board of directors has proposed to adjust the conversion price of the "Meinuo Convertible Bonds" downwards due to the stock price being below 90% of the current conversion price for at least 15 trading days within a 30-day period [33][41] - The proposed adjustment will be submitted for shareholder approval, requiring a two-thirds majority of the voting rights present at the meeting [33][41] - The current conversion price is set at 25.68 yuan per share, and the adjusted price must not be lower than the higher of the average trading price over the last 20 trading days prior to the meeting and the previous trading day's average [41][39] Group 3 - The company has approved daily related transactions for 2026, with an estimated amount not exceeding 60 million yuan, which has been reviewed and approved by independent directors [20][48] - The related party involved is Ningbo Kelkang Meinuo Pharmaceutical Co., Ltd., in which the company holds a 40% stake [24][25] - The transactions are deemed necessary for the company's normal operations and will not adversely affect the company's financial status or independence [20][29]